New treatment approaches in renal cell carcinoma-Reference-Cited by-同舟云学术

New treatment approaches in renal cell carcinoma

Published:2009-11 Issue:10 Volume:20 Page:893-900
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Facchini Gaetano,Perri Francesco,Caraglia Michele,Pisano Carmela,Striano Stefano,Marra Luigi,Fiore Francesco,Aprea Pasquale,Pignata Sandro,Iaffaioli Rosario Vincenzo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference58 articles.

1. Targeted therapy for metastatic renal cell carcinoma;Motzer;J Clin Oncol,2006

2. Renal-cell carcinoma;Motzer;N Engl J Med,1996

3. Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer;Pyrhönen;J Clin Oncol,1999

4. Interferon-alpha and survival in metastatic renal cell carcinoma: early results of a randomized controlled trial;Lancet,1999

5. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy;Fyfe;J Clin Oncol,1995

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Treatment-Related Adverse Events for Combination Therapy of Multiple Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor;Cancer Control;2024-01

2. Scapular renal cell carcinoma metastasis as a cause of high-output heart failure: a case report;BMC Cardiovascular Disorders;2022-04-05

3. Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer;Frontiers in Oncology;2019-12-11

4. Current and Emerging Treatments for Metastatic Renal Cell Carcinoma;Current Cancer Drug Targets;2018-05-22

5. 16-Hydroxycleroda-3, 13-dien-15, 16-olide inhibits the proliferation and induces mitochondrial-dependent apoptosis through Akt, mTOR, and MEK-ERK pathways in human renal carcinoma cells;Phytomedicine;2017-12